文献速递妇科肿瘤

近红外荧光检测宫颈癌和子宫癌前哨淋巴结的随机三期非劣效试验

Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial.
PubMed 文献 · Lancet Oncol · 2018-08-22

FILM试验在180例早期子宫内膜癌或宫颈癌患者中比较吲哚菁绿近红外荧光与异硫蓝染料检测前哨淋巴结。

要点

  • 吲哚菁绿近红外荧光识别前哨淋巴结优于异硫蓝染料。
  • 绿色染料识别率97%,蓝色染料47%,差异50%(95%CI 39-62)。
  • 两种染料识别的淋巴结病理确认率无显著差异。

核心结论

  • 在宫颈癌和子宫癌患者中,吲哚菁绿近红外荧光成像识别的前哨淋巴结数量多于异硫蓝染料,且两种示踪剂病理确认淋巴结组织无差异。

研究设计与样本

  • 随机、三期、多中心、非劣效性、患者内对照研究,纳入180例临床I期子宫内膜癌或宫颈癌患者,随机1:1分配至先异硫蓝后吲哚菁绿或相反顺序,所有患者接受腹腔镜手术及PINPOINT近红外荧光成像系统。

关键数值与推荐

  • 非劣效界值为5%,把握度80%,双侧显著性水平5%。
  • 主要结局为术中吲哚菁绿与异硫蓝染料识别淋巴结的效力,以组织学确认的淋巴组织数除以术中识别并切除的淋巴结数计算。

临床怎么用

  • 对于接受手术的早期宫颈癌和子宫内膜癌患者,可优先采用吲哚菁绿近红外荧光成像进行前哨淋巴结定位。

局限性

  • 13例患者因重大方案偏离被排除在符合方案分析之外。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Accurate identification of sentinel lymph nodes in patients with cancer improves detection of metastatic disease and decreases surgical morbidity. We sought to establish whether indocyanine green fluorescent dye is non-inferior to isosulfan blue dye in detecting sentinel lymph nodes in women with cervical and uterine cancers. METHODS: In this non-inferiority, within-patient comparison study, patients aged 18 years or older with clinical stage I endometrial or cervical cancer undergoing curative surgery were randomly assigned 1:1 to lymphatic mapping with isosulfan blue dye (visualised by white light) followed by indocyanine green (visualised by near-infrared imaging), or indocyanine green followed by isosulfan blue dye. Permuted block randomisation with stratification by study site was done with a computerised random number generator. All participants were masked to their randomisation assignment until after the procedure; however, investigators were not masked to the procedure used. Laparoscopic surgery with the PINPOINT near-infrared fluorescence imaging system (Stryker, Kalamazoo, MI, USA) was used in all cases. The primary outcome was efficacy of intraoperative indocyanine green with near-infrared fluorescence imaging versus that of isosulfan blue dye in the identification of lymph nodes, defined as the number of lymph nodes identified by indocyanine green and isosulfan blue dye, respectively (and confirmed as lymphoid tissue by histology), divided by the number of lymph nodes identified intraoperatively and excised. The study had a 5% non-inferiority margin needed to show non-inferiority of the frequency of lymph node detection with indocyanine green to that with isosulfan blue dye with 80% power at a 5% two-sided significance level. Analyses were done in both per-protocol and modified intention-to-treat populations. The trial was registered with ClinicalTrials.gov, number NCT02209532, and is completed and closed. FINDINGS: Between Dec 21, 2015, and June 19, 2017, 180 patients were enrolled and randomly assigned to the two groups (90 to each group); 176 patients received the intervention and were evaluable (modified intention-to-treat population). 13 patients with major protocol violations were subsequently excluded from the per-protocol population. 517 sentinel nodes were identified in the per-protocol population (n=163), of which 478 (92%) were confirmed to be lymph nodes on pathological processing: 219 (92%) of 238 nodes that were both blue and green, all seven nodes that were blue only, and 252 (95%) of 265 nodes that were green only (p=0·33). Seven sentinel lymph nodes were neither blue nor green but were removed for appearing suspicious or enlarged on visual examination. In total, 471 (97%) of 485 lymph nodes were identified with the green dye and 226 (47%) with the blue dye (difference 50%, 95% CI 39-62; p<0·0001). In the modified intention-to-treat population (n=176), 545 nodes were identified, of which 513 (94%) were confirmed to be lymph nodes on pathological processing: 229 (92%) of 248 nodes that were both blue and green, all nine nodes that were blue only, and 266 (95%) of 279 nodes that were green only (p=0·30). Nine sentinal lymph nodes were neither blue nor green but were removed for appearing suspicious or enlarged on visual examination. 495 (96%) of 513 nodes were identified with the green dye and 238 (46%) with the blue dye (50%, 39-61; p<0·0001). INTERPRETATION: Indocyanine green dye with near-infrared fluorescence imaging identified more sentinel nodes than isosulfan blue dye in women with cervical and uterine cancers, with no difference in the pathological confirmation of nodal tissue between the two mapping substances. FUNDING: Novadaq.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Frumovitz M, Plante M, Lee PS, et al. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol. 2018. PMID: 30143441. doi:10.1016/S1470-2045(18)30448-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。